Cargando…
Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production
BACKGROUND: Cell based therapies, such as bone marrow derived mesenchymal stem cells (BM-MSCs; also known as mesenchymal stromal cells), are currently under investigation for a number of disease applications. The current challenge facing the field is maintaining the consistency and quality of cells...
Autores principales: | Trivedi, Alpa, Miyazawa, Byron, Gibb, Stuart, Valanoski, Kristen, Vivona, Lindsay, Lin, Maximillian, Potter, Daniel, Stone, Mars, Norris, Philip J., Murphy, James, Smith, Sawyer, Schreiber, Martin, Pati, Shibani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469059/ https://www.ncbi.nlm.nih.gov/pubmed/30995929 http://dx.doi.org/10.1186/s12967-019-1877-4 |
Ejemplares similares
-
Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock
por: Pati, Shibani, et al.
Publicado: (2018) -
Colony Formation, Migratory, and Differentiation Characteristics of Multipotential Stromal Cells (MSCs) from “Clinically Accessible” Human Periosteum Compared to Donor-Matched Bone Marrow MSCs
por: Owston, Heather E., et al.
Publicado: (2019) -
iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
por: Lee, Hae-Ri, et al.
Publicado: (2023) -
Elevated plasma levels of TIMP-3 are associated with a higher risk of acute respiratory distress syndrome and death following severe isolated traumatic brain injury
por: Hendrickson, Carolyn M, et al.
Publicado: (2018) -
The role of MSCs and CAR-MSCs in cellular immunotherapy
por: Yan, Lun, et al.
Publicado: (2023)